Acute Myeloid Leukemia Drugs Market
1 Study Coverage
1.1 Acute Myeloid Leukemia Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Acute Myeloid Leukemia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DC regimen
1.2.3 AVD Regimen
1.2.4 VCD regimen
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Acute Myeloid Leukemia Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Acute Myeloid Leukemia Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Acute Myeloid Leukemia Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Acute Myeloid Leukemia Drugs Sales by Region
2.4.1 Global Acute Myeloid Leukemia Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Acute Myeloid Leukemia Drugs by Region (2023-2028)
2.5 Global Acute Myeloid Leukemia Drugs Revenue by Region
2.5.1 Global Acute Myeloid Leukemia Drugs Revenue by Region (2017-2022)
2.5.2 Global Acute Myeloid Leukemia Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Acute Myeloid Leukemia Drugs Sales by Manufacturers
3.1.1 Global Top Acute Myeloid Leukemia Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Acute Myeloid Leukemia Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Acute Myeloid Leukemia Drugs in 2021
3.2 Global Acute Myeloid Leukemia Drugs Revenue by Manufacturers
3.2.1 Global Acute Myeloid Leukemia Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Drugs Revenue in 2021
3.3 Global Acute Myeloid Leukemia Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Acute Myeloid Leukemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Acute Myeloid Leukemia Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Acute Myeloid Leukemia Drugs Sales by Type
4.1.1 Global Acute Myeloid Leukemia Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Acute Myeloid Leukemia Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
4.2 Global Acute Myeloid Leukemia Drugs Revenue by Type
4.2.1 Global Acute Myeloid Leukemia Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Acute Myeloid Leukemia Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Acute Myeloid Leukemia Drugs Price by Type
4.3.1 Global Acute Myeloid Leukemia Drugs Price by Type (2017-2022)
4.3.2 Global Acute Myeloid Leukemia Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Acute Myeloid Leukemia Drugs Sales by Application
5.1.1 Global Acute Myeloid Leukemia Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Acute Myeloid Leukemia Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
5.2 Global Acute Myeloid Leukemia Drugs Revenue by Application
5.2.1 Global Acute Myeloid Leukemia Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Acute Myeloid Leukemia Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Acute Myeloid Leukemia Drugs Price by Application
5.3.1 Global Acute Myeloid Leukemia Drugs Price by Application (2017-2022)
5.3.2 Global Acute Myeloid Leukemia Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Acute Myeloid Leukemia Drugs Market Size by Type
6.1.1 North America Acute Myeloid Leukemia Drugs Sales by Type (2017-2028)
6.1.2 North America Acute Myeloid Leukemia Drugs Revenue by Type (2017-2028)
6.2 North America Acute Myeloid Leukemia Drugs Market Size by Application
6.2.1 North America Acute Myeloid Leukemia Drugs Sales by Application (2017-2028)
6.2.2 North America Acute Myeloid Leukemia Drugs Revenue by Application (2017-2028)
6.3 North America Acute Myeloid Leukemia Drugs Market Size by Country
6.3.1 North America Acute Myeloid Leukemia Drugs Sales by Country (2017-2028)
6.3.2 North America Acute Myeloid Leukemia Drugs Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia Drugs Market Size by Type
7.1.1 Europe Acute Myeloid Leukemia Drugs Sales by Type (2017-2028)
7.1.2 Europe Acute Myeloid Leukemia Drugs Revenue by Type (2017-2028)
7.2 Europe Acute Myeloid Leukemia Drugs Market Size by Application
7.2.1 Europe Acute Myeloid Leukemia Drugs Sales by Application (2017-2028)
7.2.2 Europe Acute Myeloid Leukemia Drugs Revenue by Application (2017-2028)
7.3 Europe Acute Myeloid Leukemia Drugs Market Size by Country
7.3.1 Europe Acute Myeloid Leukemia Drugs Sales by Country (2017-2028)
7.3.2 Europe Acute Myeloid Leukemia Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Acute Myeloid Leukemia Drugs Market Size by Type
8.1.1 Asia Pacific Acute Myeloid Leukemia Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Acute Myeloid Leukemia Drugs Market Size by Application
8.2.1 Asia Pacific Acute Myeloid Leukemia Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Acute Myeloid Leukemia Drugs Market Size by Region
8.3.1 Asia Pacific Acute Myeloid Leukemia Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Acute Myeloid Leukemia Drugs Market Size by Type
9.1.1 Latin America Acute Myeloid Leukemia Drugs Sales by Type (2017-2028)
9.1.2 Latin America Acute Myeloid Leukemia Drugs Revenue by Type (2017-2028)
9.2 Latin America Acute Myeloid Leukemia Drugs Market Size by Application
9.2.1 Latin America Acute Myeloid Leukemia Drugs Sales by Application (2017-2028)
9.2.2 Latin America Acute Myeloid Leukemia Drugs Revenue by Application (2017-2028)
9.3 Latin America Acute Myeloid Leukemia Drugs Market Size by Country
9.3.1 Latin America Acute Myeloid Leukemia Drugs Sales by Country (2017-2028)
9.3.2 Latin America Acute Myeloid Leukemia Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Acute Myeloid Leukemia Drugs Market Size by Type
10.1.1 Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Acute Myeloid Leukemia Drugs Market Size by Application
10.2.1 Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Acute Myeloid Leukemia Drugs Market Size by Country
10.3.1 Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Ambit Biosciences Corporation
11.1.1 Ambit Biosciences Corporation Corporation Information
11.1.2 Ambit Biosciences Corporation Overview
11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ambit Biosciences Corporation Recent Developments
11.2 Celgene Corporation
11.2.1 Celgene Corporation Corporation Information
11.2.2 Celgene Corporation Overview
11.2.3 Celgene Corporation Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celgene Corporation Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celgene Corporation Recent Developments
11.3 Cephalon
11.3.1 Cephalon Corporation Information
11.3.2 Cephalon Overview
11.3.3 Cephalon Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cephalon Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cephalon Recent Developments
11.4 Clavis Pharma
11.4.1 Clavis Pharma Corporation Information
11.4.2 Clavis Pharma Overview
11.4.3 Clavis Pharma Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Clavis Pharma Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Clavis Pharma Recent Developments
11.5 Eisai
11.5.1 Eisai Corporation Information
11.5.2 Eisai Overview
11.5.3 Eisai Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eisai Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eisai Recent Developments
11.6 Genzyme Corporation
11.6.1 Genzyme Corporation Corporation Information
11.6.2 Genzyme Corporation Overview
11.6.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Genzyme Corporation Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Genzyme Corporation Recent Developments
11.7 Sunesis Pharmaceuticals
11.7.1 Sunesis Pharmaceuticals Corporation Information
11.7.2 Sunesis Pharmaceuticals Overview
11.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sunesis Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Acute Myeloid Leukemia Drugs Industry Chain Analysis
12.2 Acute Myeloid Leukemia Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Acute Myeloid Leukemia Drugs Production Mode & Process
12.4 Acute Myeloid Leukemia Drugs Sales and Marketing
12.4.1 Acute Myeloid Leukemia Drugs Sales Channels
12.4.2 Acute Myeloid Leukemia Drugs Distributors
12.5 Acute Myeloid Leukemia Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Acute Myeloid Leukemia Drugs Industry Trends
13.2 Acute Myeloid Leukemia Drugs Market Drivers
13.3 Acute Myeloid Leukemia Drugs Market Challenges
13.4 Acute Myeloid Leukemia Drugs Market Restraints
14 Key Findings in The Global Acute Myeloid Leukemia Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Acute Myeloid Leukemia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of DC regimen
Table 3. Major Manufacturers of AVD Regimen
Table 4. Major Manufacturers of VCD regimen
Table 5. Global Acute Myeloid Leukemia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Acute Myeloid Leukemia Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Acute Myeloid Leukemia Drugs Sales by Region (2017-2022) & (K Units)
Table 8. Global Acute Myeloid Leukemia Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Acute Myeloid Leukemia Drugs Sales by Region (2023-2028) & (K Units)
Table 10. Global Acute Myeloid Leukemia Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Acute Myeloid Leukemia Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Acute Myeloid Leukemia Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Acute Myeloid Leukemia Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Acute Myeloid Leukemia Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Acute Myeloid Leukemia Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Acute Myeloid Leukemia Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Acute Myeloid Leukemia Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Acute Myeloid Leukemia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Acute Myeloid Leukemia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Drugs as of 2021)
Table 22. Acute Myeloid Leukemia Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Acute Myeloid Leukemia Drugs Product Offered
Table 24. Date of Manufacturers Enter into Acute Myeloid Leukemia Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Myeloid Leukemia Drugs Sales by Type (2017-2022) & (K Units)
Table 27. Global Acute Myeloid Leukemia Drugs Sales by Type (2023-2028) & (K Units)
Table 28. Global Acute Myeloid Leukemia Drugs Sales Share by Type (2017-2022)
Table 29. Global Acute Myeloid Leukemia Drugs Sales Share by Type (2023-2028)
Table 30. Global Acute Myeloid Leukemia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Acute Myeloid Leukemia Drugs Revenue Share by Type (2017-2022)
Table 33. Global Acute Myeloid Leukemia Drugs Revenue Share by Type (2023-2028)
Table 34. Acute Myeloid Leukemia Drugs Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Acute Myeloid Leukemia Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Acute Myeloid Leukemia Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Acute Myeloid Leukemia Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Acute Myeloid Leukemia Drugs Sales Share by Application (2017-2022)
Table 39. Global Acute Myeloid Leukemia Drugs Sales Share by Application (2023-2028)
Table 40. Global Acute Myeloid Leukemia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Acute Myeloid Leukemia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Acute Myeloid Leukemia Drugs Revenue Share by Application (2017-2022)
Table 43. Global Acute Myeloid Leukemia Drugs Revenue Share by Application (2023-2028)
Table 44. Acute Myeloid Leukemia Drugs Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Acute Myeloid Leukemia Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Acute Myeloid Leukemia Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Acute Myeloid Leukemia Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Acute Myeloid Leukemia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Acute Myeloid Leukemia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Acute Myeloid Leukemia Drugs Sales by Application (2017-2022) & (K Units)
Table 51. North America Acute Myeloid Leukemia Drugs Sales by Application (2023-2028) & (K Units)
Table 52. North America Acute Myeloid Leukemia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Acute Myeloid Leukemia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Acute Myeloid Leukemia Drugs Sales by Country (2017-2022) & (K Units)
Table 55. North America Acute Myeloid Leukemia Drugs Sales by Country (2023-2028) & (K Units)
Table 56. North America Acute Myeloid Leukemia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Acute Myeloid Leukemia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Acute Myeloid Leukemia Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Acute Myeloid Leukemia Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Acute Myeloid Leukemia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Acute Myeloid Leukemia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Acute Myeloid Leukemia Drugs Sales by Application (2017-2022) & (K Units)
Table 63. Europe Acute Myeloid Leukemia Drugs Sales by Application (2023-2028) & (K Units)
Table 64. Europe Acute Myeloid Leukemia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Acute Myeloid Leukemia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Acute Myeloid Leukemia Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Acute Myeloid Leukemia Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Acute Myeloid Leukemia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Acute Myeloid Leukemia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Acute Myeloid Leukemia Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Acute Myeloid Leukemia Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Acute Myeloid Leukemia Drugs Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Acute Myeloid Leukemia Drugs Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Acute Myeloid Leukemia Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Acute Myeloid Leukemia Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Acute Myeloid Leukemia Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Acute Myeloid Leukemia Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Acute Myeloid Leukemia Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Acute Myeloid Leukemia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Acute Myeloid Leukemia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Acute Myeloid Leukemia Drugs Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Acute Myeloid Leukemia Drugs Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Acute Myeloid Leukemia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Acute Myeloid Leukemia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Acute Myeloid Leukemia Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Acute Myeloid Leukemia Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Acute Myeloid Leukemia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Acute Myeloid Leukemia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Acute Myeloid Leukemia Drugs Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Ambit Biosciences Corporation Corporation Information
Table 107. Ambit Biosciences Corporation Description and Major Businesses
Table 108. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Ambit Biosciences Corporation Recent Developments
Table 111. Celgene Corporation Corporation Information
Table 112. Celgene Corporation Description and Major Businesses
Table 113. Celgene Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Celgene Corporation Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Celgene Corporation Recent Developments
Table 116. Cephalon Corporation Information
Table 117. Cephalon Description and Major Businesses
Table 118. Cephalon Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Cephalon Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Cephalon Recent Developments
Table 121. Clavis Pharma Corporation Information
Table 122. Clavis Pharma Description and Major Businesses
Table 123. Clavis Pharma Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Clavis Pharma Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Clavis Pharma Recent Developments
Table 126. Eisai Corporation Information
Table 127. Eisai Description and Major Businesses
Table 128. Eisai Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Eisai Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Eisai Recent Developments
Table 131. Genzyme Corporation Corporation Information
Table 132. Genzyme Corporation Description and Major Businesses
Table 133. Genzyme Corporation Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Genzyme Corporation Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Genzyme Corporation Recent Developments
Table 136. Sunesis Pharmaceuticals Corporation Information
Table 137. Sunesis Pharmaceuticals Description and Major Businesses
Table 138. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Sunesis Pharmaceuticals Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Acute Myeloid Leukemia Drugs Distributors List
Table 144. Acute Myeloid Leukemia Drugs Customers List
Table 145. Acute Myeloid Leukemia Drugs Market Trends
Table 146. Acute Myeloid Leukemia Drugs Market Drivers
Table 147. Acute Myeloid Leukemia Drugs Market Challenges
Table 148. Acute Myeloid Leukemia Drugs Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Myeloid Leukemia Drugs Product Picture
Figure 3. Global Acute Myeloid Leukemia Drugs Market Share by Type in 2021 & 2028
Figure 3. DC regimen Product Picture
Figure 4. AVD Regimen Product Picture
Figure 5. VCD regimen Product Picture
Figure 6. Global Acute Myeloid Leukemia Drugs Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Acute Myeloid Leukemia Drugs Report Years Considered
Figure 11. Global Acute Myeloid Leukemia Drugs Sales 2017-2028 (K Units)
Figure 12. Global Acute Myeloid Leukemia Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Acute Myeloid Leukemia Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global Acute Myeloid Leukemia Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Acute Myeloid Leukemia Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global Acute Myeloid Leukemia Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America Acute Myeloid Leukemia Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. North America Acute Myeloid Leukemia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Acute Myeloid Leukemia Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Acute Myeloid Leukemia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Acute Myeloid Leukemia Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Acute Myeloid Leukemia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Acute Myeloid Leukemia Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Acute Myeloid Leukemia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Acute Myeloid Leukemia Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Acute Myeloid Leukemia Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Acute Myeloid Leukemia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Acute Myeloid Leukemia Drugs in the World: Market Share by Acute Myeloid Leukemia Drugs Revenue in 2021
Figure 29. Global Acute Myeloid Leukemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Acute Myeloid Leukemia Drugs Sales Share by Country (2017-2028)
Figure 39. North America Acute Myeloid Leukemia Drugs Revenue Share by Country (2017-2028)
Figure 40. the United States Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Acute Myeloid Leukemia Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Acute Myeloid Leukemia Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. UK Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Acute Myeloid Leukemia Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Acute Myeloid Leukemia Drugs Revenue Share by Region (2017-2028)
Figure 59. China Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Acute Myeloid Leukemia Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America Acute Myeloid Leukemia Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Acute Myeloid Leukemia Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Acute Myeloid Leukemia Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Acute Myeloid Leukemia Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Acute Myeloid Leukemia Drugs Value Chain
Figure 87. Acute Myeloid Leukemia Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
